Jiangsu Hengrui Medicine
600276.SS
#480
Rank
NZ$72.81 B
Marketcap
$11.42
Share price
-1.82%
Change (1 day)
1.91%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$11.76 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are NZ$11.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31NZ$9.67 B7.22%
2021-12-31NZ$9.02 B22.25%
2020-12-31NZ$7.37 B26%
2019-12-31NZ$5.85 B20.02%
2018-12-31NZ$4.88 B24.99%
2017-12-31NZ$3.90 B31.05%
2016-12-31NZ$2.97 B14.95%
2015-12-31NZ$2.59 B38.38%
2014-12-31NZ$1.87 B29.01%
2013-12-31NZ$1.45 B26.37%
2012-12-31NZ$1.14 B16.96%
2011-12-31NZ$0.98 B28.62%
2010-12-31NZ$0.76 B26.33%
2009-12-31NZ$0.60 B6.02%
2008-12-31NZ$0.57 B54.8%
2007-12-31NZ$0.36 B37.93%
2006-12-31NZ$0.26 B14.57%
2005-12-31NZ$0.23 B9.5%
2004-12-31NZ$0.21 B-21.16%
2003-12-31NZ$0.26 B-2.92%
2002-12-31NZ$0.27 B-14.59%
2001-12-31NZ$0.32 B